Degenerative disc disease: causes, symptoms, anatomy, market trends and emerging treatment strategies

Abstract

Degenerative disk disease (DDD) is a progressive condition characterized by the breakdown of intervertebral disks. This represents a significant concern in spinal health due to its impact on flexibility, mobility, and quality of life. Although the exact causes of this disease remain unknown, its prevalence increases with age, and is influenced by several risk factors, including prior injury, excessive use, and repetitive activities. DDD presents a wide array of symptoms, from back or neck pain to numbness or tingling in the limbs, with a varying degree of pain, highlighting its complex nature. Intervertebral disks are vital to the vertebral column’s structure and function and undergo degenerative changes with aging, resulting in hydration loss, disc height reduction, and potential disc herniation. This can cause significant discomfort. Despite the avascular nature of these discs, they serve as shock absorbers and facilitate a range of spinal movements. As of 2021, the global market for DDD treatment was valued at 26.05 billion USD and is projected to reach 45.92 billion USD by 2029. The increasing market size, combined with the launch of innovative treatment products, signifies the growing emphasis on addressing DDD. The high prevalence of DDD-induced low back pain and the higher incidence in low- and middle-income countries underscore the urgent need for effective management strategies. This paper provides a comprehensive overview of DDD, examining its causes, risk factors, symptoms, anatomical aspects, and market trends, aiming to promote understanding and guide future research and treatment approaches;